Ultragenyx Pharmaceutical EBITDA 2012-2024 | RARE
- Ultragenyx Pharmaceutical 2023 EBITDA was -0.556B, a 11.46% decline from 2022.
- Ultragenyx Pharmaceutical 2022 EBITDA was -0.628B, a 73.53% increase from 2021.
- Ultragenyx Pharmaceutical 2021 EBITDA was -0.362B, a 14.16% increase from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.